High Resolution Imaging for Early and Better Detection of Bladder Cancer
Completed
- Conditions
- Bladder Cancer
- Interventions
- Device: Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope
- Registration Number
- NCT02340650
- Brief Summary
The goal of this study is to develop, optimize, and validate a High Resolution Imaging System in the bladder that displays images in real-time, providing automated diagnostic criteria for bladder cancer screening. High resolution images of normal bladder tissue and suspicious bladder lesions will be collected from patients who present to the study site for clinical evaluation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
- Diagnosed with clinically suspicious bladder lesion or clinical finding; or who are undergoing cystoscopy as part of their routine clinical care.
- Must be willing and able to participate and provide written informed consent
- Women of childbearing age who have the possibility of being pregnant must have a negative pregnancy test prior to participation
Exclusion Criteria
- Patient with sufficient evidence of cognitive impairment that limits the subject's ability to understand the protocol, provide informed consent, or to comply with the protocol procedures.
- Women with the possibility of having the pregnancy.
- Patients having acute infection.
- Person with Lidocaine sensitivity.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Bladder Cancer Patients Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope High resolution images of normal bladder tissue and suspicious bladder lesions will be collected from patients who present to the study site for clinical evaluation.
- Primary Outcome Measures
Name Time Method Specificity of Bladder Cancer Detection Imaging baseline (at the time of imaging)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Lyndon B. Johnson General Hospital
🇺🇸Houston, Texas, United States